Medicare Enrolled

Dr. Nikhil Inamdar, M.D.

Gastroenterology · Houston, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
11920 ASTORIA BLVD, Houston, TX 77089
2814806264
In practice since 2006 (19 years)
NPI: 1093723132 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Inamdar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Inamdar? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Inamdar

Dr. Nikhil Inamdar is a gastroenterology in Houston, TX, with 19 years in practice. Based on federal Medicare data, Dr. Inamdar performed 1,769 Medicare services across 798 unique beneficiaries.

Between the years covered by Open Payments, Dr. Inamdar received a total of $3,719 from 33 pharmaceutical and/or device companies across 171 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Inamdar is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 8% volume in TX$ $3,719 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,769
Medicare services
Top 8% in TX for gastroenterology
798
Unique beneficiaries
$70
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~93 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Chronic care management, additional 20 min/month536$38$152
Office visit, established patient (30-39 min)375$93$217
Chronic care management, first 20 min/month296$49$100
Office visit, established patient (20-29 min)197$63$148
Upper GI endoscopy with biopsy87$64$680
Removal of polyps or growths of large bowel using an endoscope with mechanical snare53$213$1,067
New patient office visit (45-59 min)49$123$332
New patient office visit (30-44 min)33$78$219
Limited ultrasound scan of abdomen24$49$285
Ultrasound of abdomen and pelvis artery and vein blood flow23$78$338
Colorectal cancer screening; colonoscopy on individual at high risk20$171$778
Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm19$92$649
Colonoscopy with biopsy17$99$847
Office visit, established patient, complex (40-54 min)14$118$293
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk14$186$781
Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare12$144$827
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,719
Total received (2018-2024)
Avg $531/year across 7 years
Top 46% in TX for gastroenterology
33
Companies
171
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,719 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$720
2023
$1,008
2022
$781
2021
$71
2020
$67
2019
$254
2018
$817

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$1,070
AbbVie, Inc.
$449
Janssen Scientific Affairs, LLC
$274
Merck Sharp & Dohme Corporation
$168
Takeda Pharmaceuticals U.S.A., Inc.
$165
Celgene Corporation
$155
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$150
Gilead Sciences, Inc.
$146
Axonics, Inc.
$115
PFIZER INC.
$85
Merck Sharp & Dohme LLC
$76
GENZYME CORPORATION
$73
Alexion Pharmaceuticals, Inc.
$68
Intercept Pharmaceuticals, Inc.
$67
AbbVie Inc.
$64
Allergan Inc.
$62
RedHill Biopharma Inc.
$51
Ardelyx, Inc.
$49
QOL Medical, LLC
$47
Ironwood Pharmaceuticals, Inc
$44
INTERCEPT PHARMACEUTICALS, INC.
$44
Astellas Pharma US Inc
$43
Ferring Pharmaceuticals Inc.
$40
Janssen Biotech, Inc.
$39
Phathom Pharmaceuticals, Inc.
$26
UCB, Inc.
$25
Boston Scientific Corporation
$21
Braintree Laboratories, Inc.
$21
Celltrion USA Inc.
$19
Romark Laboratories, LC
$19
IRONWOOD PHARMACEUTICALS, INC
$16
AIMMUNE THERAPEUTICS, INC.
$15
Medtronic USA, Inc.
$12
Top 3 companies account for 48.2% of total payments
Associated products mentioned in payments ›
APRISO · Alinia Tablets 500mg 30 count bottle · Axonics · BYSTOLIC · CAPTIVATOR II · CLENPIQ · CREON · Cimzia · DIFICID · DUPIXENT · ENTERRA · ENTYVIO · EOHILIA · Entyvio · GATTEX · HUMIRA · Humira · IBSRELA · LINZESS · Linzess · MAVYRET · Mavyret · Motegrity · OCALIVA · REMICADE · RENFLEXIS · RINVOQ · SKYRIZI · STELARA · SUTAB · Sucraid · Talicia · ULTOMIRIS · VEGZELMA · VIBERZI · VOQUEZNA · XELJANZ · XIFAXAN · Xtandi · ZENPEP · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $210 per 100 Medicare services performed
Looking for a gastroenterology in Houston?
Compare gastroenterologys in the Houston area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologys nearby

Geographic Context

Gastroenterologys within 10 mi
218
Per 100K population
4.6
County median income
$73,104
Nearest hospital
HCA HOUSTON HEALTHCARE SOUTHEAST
4.7 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Inamdar is a clinical cardiology specialist, with above-average Medicare volume (top 8% in TX), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Inamdar experienced with chronic care management, additional 20 min/month?
Based on Medicare claims data, Dr. Inamdar performed 536 chronic care management, additional 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Inamdar receive payments from pharmaceutical companies?
Yes. Dr. Inamdar received a total of $3,719 from 33 companies across 171 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Inamdar's costs compare to other gastroenterologys in Houston?
Dr. Inamdar's average Medicare payment per service is $70. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Inamdar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →